<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04296903</url>
  </required_header>
  <id_info>
    <org_study_id>MID-C-AIS-03-18</org_study_id>
    <nct_id>NCT04296903</nct_id>
  </id_info>
  <brief_title>Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)</brief_title>
  <official_title>Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Apifix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Apifix</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_ppsd>Yes</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ApiFix MID-C System is a unidirectional expandable rod, designed to be connected
      unilaterally to the spine via 2 anchor points on the concave side of a scoliotic deformity
      above and below the apex of the major curvature to treat adolescent idiopathic scoliosis. The
      MID-C System is designed to act as an internal brace. Patients implanted with the device in
      the US within 2 years of FDA's approval of H17001 should be enrolled in the study. A minimum
      number of 200 patients will be enrolled in this study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 31, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2028</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2027</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective Registry, multi center, single arm, non-randomized, new enrollment cohort study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maintenance of major Cobb angle ≤ 40° 5 years post-surgery</measure>
    <time_frame>5 years</time_frame>
    <description>Spinal Cobb angle will be measured at 5 years post op. the percent of patients with Cobb angle ≤ 40° 5 years post-surgery will be calculated</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Adolescent Idiopathic Scoliosis</condition>
  <arm_group>
    <arm_group_label>MID-C treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MID-C System</intervention_name>
    <description>Minimal invasive deformity correction system for the treatment of AIS</description>
    <arm_group_label>MID-C treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adolescent Idiopathic Scoliosis classified as Lenke Type 1 or Type 5 curves;

          -  Cobb angle between 40-60 degrees (inclusive);

          -  Flexible curve that that reduces to ≤ 30 degrees on lateral side-bending radiographs
             or as evident by traction x-ray;

          -  Kyphosis angles of ≤ 55 degrees measured from T5 to T12;

          -  Appropriate candidate for posterior surgical approach;

          -  Patient has good general health;

          -  Patient has no known hypersensitivity or allergies to titanium;

          -  Patient's guardian signs a written informed consent form (ICF).

        Exclusion Criteria:

          -  Any type of non-idiopathic scoliosis;

          -  Any main thoracic deformity that includes vertebral levels and cranial including to
             T2;

          -  Known history of existing malignancy, or any systemic or local infection;

          -  Spinal cord abnormalities that require treatment;

          -  Known neurological deficit (defined as motor grade &lt; 5/5);

          -  Known poor bone quality defined as T score -1.5 or less;

          -  For female Patient, pregnancy;

          -  Previous spine surgery;

          -  Active systemic disease, such as AIDS, HIV, or active infection;

          -  Active infection or the skin is compromised at the surgical site;

          -  Systemic disease that would affect the Patient's welfare or overall outcome of the
             study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Daphna Zaaroor-Regev, PhD</last_name>
    <phone>+972523763653</phone>
    <email>Daphna@apifix.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paul Mraz</last_name>
    <phone>+1 781 934 5441</phone>
    <email>pmraz@orthopediatrics.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rady Children's Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Peter Newton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Burt Yaszay, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Salil Upasani, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida Health Shands Hospital</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Laurel Blakemore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephanie Ihnow, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Atlanta (CHOA)</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30329</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Timothy Oswald, MD</last_name>
      <phone>404-321-9900</phone>
      <email>toswald@mypedsortho.com</email>
    </contact>
    <contact_backup>
      <last_name>Gilbert Chan, MD</last_name>
      <phone>404-321-9900</phone>
      <email>gchan@mypedsortho.com</email>
    </contact_backup>
    <investigator>
      <last_name>Timothy Oswald, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gilbert Chan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nigel Price, MD</last_name>
      <phone>816-234-3693</phone>
      <email>nprice@cmh.edu</email>
    </contact>
    <contact_backup>
      <last_name>Richard Schwend, MD</last_name>
      <email>rmschwend@cmh.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Nigel Price, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard Schwend, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Anderson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Tim Hresko, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dan Hedequist, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noelle Larson, MD</last_name>
      <phone>507-284-3660</phone>
      <email>Larson.noelle@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Todd Milbrandt, MD</last_name>
      <phone>507-284-3660</phone>
      <email>Milbrandt.todd@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Noelle Larson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Todd Milbrandt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lily Eaker</last_name>
      <phone>212-241-1678</phone>
      <email>Lily.Eaker@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Baron Lonner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wesley Bronson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sanford Univ. of South Dakota Medical Center</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Geoffrey Haft, MD</last_name>
      <phone>605-328-3944</phone>
      <email>Geoffrey.haft@sanfordhealth.org</email>
    </contact>
    <investigator>
      <last_name>Geoffrey Haft, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 1, 2020</study_first_submitted>
  <study_first_submitted_qc>March 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2020</study_first_posted>
  <last_update_submitted>July 15, 2020</last_update_submitted>
  <last_update_submitted_qc>July 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scoliosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

